68 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
MNTA Momenta Pharmaceuticals, Inc. $27.4 $2.15B N/A
Article Searches
Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/773609/analysts-estimate-momenta-pharmaceuticals-mnta-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-773609 Feb 19, 2020 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can The Uptrend Continue for Momenta Pharmaceuticals? http://www.zacks.com/stock/news/730488/can-the-uptrend-continue-for-momenta-pharmaceuticals?cid=CS-ZC-FT-tale_of_the_tape|20_day_moving_average-730488 Jan 23, 2020 - As of late, it has definitely been a great time to be an investor Momenta Pharmaceuticals
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495 Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Momenta Pharmaceuticals Inc (MNTA) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/10/31/momenta-pharmaceuticals-inc-mnta-q3-2019-earnings.aspx?source=iedfolrf0000001 Oct 31, 2019 - MNTA earnings call for the period ending September 30, 2019.
Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4301058-momenta-pharmaceuticals-inc-mnta-ceo-craig-wheeler-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Oct 31, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q3 2019 Earnings Conference Call October 31, 2019, 08:30 AM ET Company Participants Patty Eisenhaur - VP of IR and Corporate Communications Craig Wheeler -
Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/595198/momenta-pharmaceuticals-mnta-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-595198 Oct 31, 2019 - Momenta (MNTA) delivered earnings and revenue surprises of -14.29% and 39.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Momenta Pharmaceuticals (MNTA) Expected to Beat Earnings Estimates: Should You Buy? http://www.zacks.com/stock/news/582161/momenta-pharmaceuticals-mnta-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-582161 Oct 24, 2019 - Momenta (MNTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4260113-momenta-pharmaceuticals-inc-mnta-ceo-craig-wheeler-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 05, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q1 2019 Earnings Conference Call May 02, 2019, 08:30 ET Company Participants Patricia Eisenhaur - VP, IR & Communications Craig Wheeler - President, CEO
Momenta Pharmaceuticals Inc (MNTA) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/02/momenta-pharmaceuticals-inc-mnta-q1-2019-earnings.aspx?source=iedfolrf0000001 May 02, 2019 - MNTA earnings call for the period ending March 31, 2019.
Momenta Pharmaceuticals (MNTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release http://www.zacks.com/stock/news/403482/momenta-pharmaceuticals-mnta-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release?cid=CS-ZC-FT-403482 Apr 25, 2019 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Pages: 1234567

Page 1>